Get started
Author

Yiangos Psaras

Observed names: Psaras, Yiangos, Y Psaras
ORCID: 0000-0002-8697-6121
Observed ORCID: 0000-0002-8697-6121
OpenAlex ID: A5036799393
CalTrack: High-Throughput Automated Calcium Transient Analysis in Cardiomyocytes
2021 · Yiangos Psaras, Francesca Margara, et al. · Circulation Research · 62
PDF
Mechanism based therapies enable personalised treatment of hypertrophic cardiomyopathy
2022 · Francesca Margara, Yiangos Psaras, et al. · Scientific Reports · 44
PDF
Comparing the effects of chemical Ca2+ dyes and R-GECO on contractility and Ca2+ transients in adult and human iPSC cardiomyocytes
2023 · Paul Robinson, Alexander J. Sparrow, et al. · Journal of Molecular and Cellular Cardiology · 24
PDF
Assaying the myosin super-relaxed state across muscle types, cells and proteins for understanding muscle biology and use in drug discovery
2025 · Samuel T. M. Jones, Flair E. Paradine Cullup, et al. · Nature Protocols · 7
Targeted genetic therapies for inherited disorders that affect both cardiac and skeletal muscle
2023 · Yiangos Psaras, Christopher N. Toepfer · Experimental Physiology · 3
PDF
Abstract 402: Defining Diverse Disease Pathomechanisms Across Thick And Thin Filament Hypertrophic Cardiomyopathy Variants.
2021 · Christopher Toepfer, Yiangos Psaras, et al. · Circulation Research · 3
Transcriptional and functional effects of mavacamten in multiple porcine and human models with hypertrophic cardiomyopathy
2025 · Elisa Kiselev, Wilson Agyapong, et al. · British Journal of Pharmacology · 2
PDF
Human iPSC-CMs and in-silico technologies define mechanisms and accelerate targeted pharmacogenetics in hypertrophic cardiomyopathy
2022 · Francesca Margara, Yiangos Psaras, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2
PDF
Unmasking Supervillin : SVIL haploinsufficiency causes hypertrophic cardiomyopathy by impairing mechanotransduction and cellular energetics
2026 · Yifan J. Li, Yiangos Psaras, et al. · bioRxiv (Cold Spring Harbor Laboratory)
Precision targeting of troponin I phosphorylation prevents diastolic dysfunction while preserving systolic performance
2026 · Chao, Ying-Chi, McAndrew, Debra J., et al. · ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam)
PDF
Unmasking Supervillin: Functional Insights in Hypertrophic Cardiomyopathy using iPSC-derived Cardiomyocytes
2026 · Yifan (Joshua) Li, Yiangos Psaras, et al. · Journal of Molecular and Cellular Cardiology Plus
Precision Targeting of Troponin I Phosphorylation Prevents Diastolic Dysfunction while Preserving Systolic Performance
2025 · Ying-Chi Chao, Debra J. McAndrew, et al. · bioRxiv (Cold Spring Harbor Laboratory)
PDF
Combining human-based in silico and in vitro models of inherited cardiac diseases for drug safety and efficacy evaluation
2021 · Francesca Margara, Yiangos Psaras, et al. · Journal of Pharmacological and Toxicological Methods
Human-based computational and experimental investigation of disease mechanisms in mutation-specific hypertrophic cardiomyopathy
2021 · F Margara, Y Psaras, et al. · EP Europace
Works count: 14
Citation count: 147
H-index: 4
I10-index: 3
Year
Topic
Type